Antiplatelet Therapy in STEMI: The Case for Prasugrel - Paul A. Gurbel, MD

↳ This is a section part of Moment: CRT 2015 Endovascular - Optimization of Anticoagulation for STEMI Therapy

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$7.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Antiplatelet Therapy in STEMI: The Case for Prasugrel presented by Paul A. Gurbel, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$7.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Radiologists
  • Vascular Surgeons
  • Interventional Fellows

Supported by an educational grant from AstraZeneca

Session Name: Optimization of Anticoagulation for STEMI Therapy

Track: Endovascular

Learning Objectives

Update in advances in endovascular procedures

Other Components in this Moment

Overview
Case Presentation - Nevin C. Baker, DO
Antiplatelet Therapy in STEMI: The Case for Prasugrel - Paul A. Gurbel, MD
Antiplatelet Therapy for STEMI: The Case for Ticagrelor - David J. Cohen, MD
Antiplatelet Therapy for STEMI: The Case for Cangrelor - Gregg W. Stone, MD
Antiplatelet Therapy for STEMI: The Case for Clopidogrel - Sunil V. Rao, MD
Loading Simple Education